|
|
|
|
||
AZD 8701Development and Characterization of AZD8701, a High Affinity Antisense Oligonucleotide Targeting FOXP3 to Relieve Immunosuppression in Cancer
A. Robert MacLeod, PhD, Ionis Pharmaceuticals #otsmunich |
return to message board, top of board |